Associated Papers
Accurate affinity models for SH2 domains from peptide binding assays and free-energy regression.
Gagoski D et al.
Protein Science : a Publication of the Protein Society, 2025
Accurate sequence-to-affinity models for SH2 domains from multi-round peptide binding assays coupled with free-energy regression.
Gagoski D et al.
Biorxiv : the Preprint Server for Biology, 2025
Childhood Multiple Endocrine Neoplasia (MEN) Syndromes: Genetics, Clinical Heterogeneity and Modifying Genes.
Lanzaro F et al.
Journal of Clinical Medicine, 2024
Beyond MEN1, When to Think About MEN4? Retrospective Study on 5600 Patients in the French Population and Literature Review.
Chevalier B et al.
The Journal of Clinical Endocrinology and Metabolism, 2024
Advancing precision oncology through systematic germline and tumor genetic analysis: The oncogenetic point of view on findings from a prospective multicenter clinical trial of 666 patients.
Mazel B et al.
Cancer Medicine, 2023
Novel germline variants of CDKN1B and CDKN2C identified during screening for familial primary hyperparathyroidism.
Mazarico-Altisent I et al.
Journal of Endocrinological Investigation, 2023
Multiple endocrine neoplasia type 4: a new member of the MEN family.
Singeisen H et al.
Endocrine Connections, 2023
Case Report: New CDKN1B Mutation in Multiple Endocrine Neoplasia Type 4 and Brief Literature Review on Clinical Management.
Lavezzi E et al.
Frontiers in Endocrinology, 2022
Lysine acetylation regulates the interaction between proteins and membranes.
Okada AK et al.
Nature Communications, 2021
CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer.
Viotto D et al.
The Journal of Pathology, 2021
Prevalence and clinical implications of germline predisposition gene mutations in patients with acute myeloid leukemia.
Kim B et al.
Scientific Reports, 2020
Multiple Endocrine Neoplasia Type 4: Novel CDNK1B variant and immune anomalies.
Chevalier B et al.
Annales D'endocrinologie, 2020
Clinical Features of Multiple Endocrine Neoplasia Type 4: Novel Pathogenic Variant and Review of Published Cases.
Frederiksen A et al.
The Journal of Clinical Endocrinology and Metabolism, 2019
Landscape of CDKN1B Mutations in Luminal Breast Cancer and Other Hormone-Driven Human Tumors.
Cusan M et al.
Frontiers in Endocrinology, 2018
MEN4 and CDKN1B mutations: the latest of the MEN syndromes.
Alrezk R et al.
Endocrine-related Cancer, 2017
p27Kip1 and human cancers: A reappraisal of a still enigmatic protein.
Bencivenga D et al.
Cancer Letters, 2017
Targeted sequencing of 36 known or putative colorectal cancer susceptibility genes.
DeRycke MS et al.
Molecular Genetics & Genomic Medicine, 2017
A Possible New Multiple Endocrine Neoplasia Mutation in a Patient with a Prototypic Multiple Endocrine Neoplasia Presentation.
Buzzola R et al.
Cardiorenal Medicine, 2016
The unpredictable consequences of CDKN1B/p27Kip1 mutations in cancer.
Borriello A et al.
Cell Cycle (georgetown, Tex.), 2015
A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization.
Molatore S et al.
Human Mutation, 2010